MX338514B - Preparacion de intermediarios de posaconazol. - Google Patents

Preparacion de intermediarios de posaconazol.

Info

Publication number
MX338514B
MX338514B MX2012013332A MX2012013332A MX338514B MX 338514 B MX338514 B MX 338514B MX 2012013332 A MX2012013332 A MX 2012013332A MX 2012013332 A MX2012013332 A MX 2012013332A MX 338514 B MX338514 B MX 338514B
Authority
MX
Mexico
Prior art keywords
preparation
posaconazole
intermediates
posaconazole intermediates
formula
Prior art date
Application number
MX2012013332A
Other languages
English (en)
Other versions
MX2012013332A (es
Inventor
Dominic De Souza
Shreerang V Joshi
Sachin Bhuta
Abhinay C Pise
Dattatraya N Chavan
Shashikant D Metkar
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of MX2012013332A publication Critical patent/MX2012013332A/es
Publication of MX338514B publication Critical patent/MX338514B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Furan Compounds (AREA)

Abstract

La presente invención se refiere a un proceso para la preparación de un compuesto quiral de la fórmula (IX) o una sal del mismo, en donde Y1 y Y2 son independientemente E o CI, de preferencia F, al compuesto cristalino de la fórmula (IX) como tal, y a su uso para la preparación de un agente antimicótico.
MX2012013332A 2010-05-19 2011-05-18 Preparacion de intermediarios de posaconazol. MX338514B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10163215 2010-05-19
PCT/EP2011/058036 WO2011144656A1 (en) 2010-05-19 2011-05-18 Preparation of posaconazole intermediates

Publications (2)

Publication Number Publication Date
MX2012013332A MX2012013332A (es) 2013-02-01
MX338514B true MX338514B (es) 2016-04-20

Family

ID=42341764

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012013332A MX338514B (es) 2010-05-19 2011-05-18 Preparacion de intermediarios de posaconazol.

Country Status (10)

Country Link
US (1) US9073904B2 (es)
EP (1) EP2571868B1 (es)
JP (1) JP2013532131A (es)
CN (1) CN102892762B (es)
AU (1) AU2011254657B2 (es)
BR (1) BR112012029226A2 (es)
CA (1) CA2798007C (es)
MX (1) MX338514B (es)
RU (1) RU2580318C2 (es)
WO (1) WO2011144656A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX342850B (es) 2010-05-19 2016-10-14 Sandoz Ag Proceso para la preparacion de triazolonas quirales.
AU2011254656B2 (en) 2010-05-19 2015-04-16 Sandoz Ag Process for the preparation of chiral hydrazides
BR112012029228A2 (pt) 2010-05-19 2021-08-03 Sandoz Ag processo para a preparação de um sal de cloreto de hidrogênio, sal de cloreto de hidrogênio, sal de cloreto de hidrogênio cristalino, uso de um sal e uso do processo
CN103635465A (zh) 2011-06-16 2014-03-12 桑多斯股份公司 制备手性化合物的方法
EP2746266A1 (en) * 2012-12-19 2014-06-25 Basf Se New substituted triazoles and imidazoles and their use as fungicides
CN103086885B (zh) * 2013-02-28 2015-04-01 天津大学仁爱学院 一种泊沙康唑中间体的制备方法
EP2789610A1 (en) * 2013-04-10 2014-10-15 Sandoz Ag Purification of Posaconazole Intermediates
CN105777720B (zh) * 2014-12-26 2018-09-21 博瑞生物医药（苏州）股份有限公司 一种泊沙康唑中间体的新晶型及制备方法
RU2750898C2 (ru) * 2015-09-23 2021-07-05 Биокон Лимитед Кристаллические формы промежуточного соединения позаконазола и способ получения аморфного позаконазола
CN105622413B (zh) * 2016-01-14 2017-11-24 宁波新凯生物科技有限公司 2‑[2‑(2，4‑二氟苯基)烯丙基]‑1，3‑丙二酸二乙酯的合成方法
CN105777486B (zh) * 2016-03-30 2018-09-11 浙江大学宁波理工学院 一种2-[2-(2，4-二氟苯基)-2-丙烯-1-基]-1，3-丙二醇的合成方法
CN105732310B (zh) * 2016-03-30 2018-01-23 宁波新凯生物科技有限公司 2‑[2‑(2，4‑二氟苯基)‑2‑丙烯‑1‑基]‑1，3‑丙二醇的合成方法
CN105753693B (zh) * 2016-03-30 2017-12-22 宁波新凯生物科技有限公司 2‑甲基丙酸‑[(2s)‑4‑(2，4‑二氟苯基)‑2‑羟甲基‑4‑戊烯‑1‑基]酯的合成方法

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8307232D0 (en) * 1983-03-16 1983-04-20 Pfizer Ltd Antifungal agents
DE3544983A1 (de) 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
IL103558A0 (en) 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals
US5595872A (en) 1992-03-06 1997-01-21 Bristol-Myers Squibb Company Nucleic acids encoding microsomal trigyceride transfer protein
US5403937A (en) * 1993-04-30 1995-04-04 Schering Corporation Process for preparing intermediates for the synthesis of antifungal agents
US5349099A (en) 1993-12-13 1994-09-20 Schering Corporation Process for preparing intermediates for the synthesis of antifungal agents
CZ294823B6 (cs) 1993-12-21 2005-03-16 Schering Corporation Fungicidní tetrahydrofurany
US5714490A (en) 1993-12-21 1998-02-03 Schering Corporation Tetrahydrofuran antifungals
US5693626A (en) 1993-12-21 1997-12-02 Schering Corporation Tetrahydrofuran antifungals
US5710154A (en) 1993-12-21 1998-01-20 Schering Corporation Tetrahydrofuran antifungals
NZ270418A (en) 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions
US5486625A (en) * 1994-07-08 1996-01-23 Schering Corporation Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents
US5616777A (en) 1995-04-19 1997-04-01 Schering Corporation Chiral hydrazine derivatives
US5625064A (en) * 1995-04-19 1997-04-29 Schering Corporation Process for the preparation of triazolones
AR002751A1 (es) * 1995-06-02 1998-04-29 Schering Corp Antifungicos de tetrahidrofurano, composiciones farmaceuticas que los contienen y el uso de los compuestos para preparar composiciones farmaceuticas utiles para el tratamiento de infecciones fungicas
WO1997000255A1 (en) * 1995-06-19 1997-01-03 Schering Corporation Tetrahydrofuran antifungals
KR100456181B1 (ko) 1995-12-20 2004-12-31 쉐링 코포레이션 항진균제합성용중간체의제조방법
SK85998A3 (en) 1995-12-20 1999-02-11 Schering Corp Process for preparation of hydrazides
EP0885394B1 (de) 1996-03-08 2000-08-16 Octapharma AG Verfahren zur eignungsprüfung von faktor viii-haltigen proteinfraktionen
US5834472A (en) 1996-05-24 1998-11-10 Schering Corporation Antifungal composition with enhanced bioavailability
US5972381A (en) 1996-06-28 1999-10-26 Schering Corporation Solid solution of an antifungal agent with enhanced bioavailability
ZA989063B (en) 1997-10-07 1999-04-06 Schering Corp Crystalline antifungal polymorph
US6713481B1 (en) 1997-10-17 2004-03-30 David R. Andrews Crystalline antifungal polymorph
AU1465301A (en) 1999-11-08 2001-06-06 Schering Corporation Process for preparing n-(4-hydroxy-phenyl)-n'-(4'-aminophenyl)-piperazine
US6355801B1 (en) 1999-11-08 2002-03-12 Schering Corporation Process for preparing N-(4-hydroxyphenyl)-N′-(4′-aminophenyl)-piperazine
AU2002257104B2 (en) 2001-04-03 2006-02-09 Merck Sharp & Dohme Corp. Antifungal composition with enhanced bioavailability
US20090099364A1 (en) 2004-02-02 2009-04-16 Pfizer Inc. Process for preparation of 1-(2s,3s)-2-benzhydryl-n-(5- tert-butyl-2-methoxybenzyl)quinuclidin-3-amine
CA2567803A1 (en) 2004-05-28 2005-12-15 Schering Corporation Injectable pharmaceutical suspension comprising posaconazole
MY142804A (en) 2004-07-01 2011-01-14 Opko Health Inc Nk1 antagonists
BRPI0710156A2 (pt) 2006-04-20 2012-06-05 Glaxo Group Ltd composto ou um sal do mesno, composição, combinação, e, uso de um composto.
SG170047A1 (en) 2006-05-30 2011-04-29 Elan Pharma Int Ltd Nanoparticulate posaconazole formulations
CN102702185A (zh) 2007-04-27 2012-10-03 卫材R&D管理有限公司 杂环取代吡啶衍生物的盐的结晶
CA2703257C (en) 2007-10-29 2013-02-19 Amgen Inc. Benzomorpholine derivatives and methods of use
WO2009129297A1 (en) 2008-04-15 2009-10-22 Schering Corporation Semi-solid oral pharmaceutical compositions
WO2009141837A2 (en) * 2008-05-21 2009-11-26 Ind-Swift Laboratories Limited Process for preparing posaconazole and intermediates thereof
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
AU2009339445A1 (en) 2009-02-05 2011-08-18 Targeted Delivery Technologies Limited Methods of reducing the proliferation and viability of microbial agents
BR112012029228A2 (pt) 2010-05-19 2021-08-03 Sandoz Ag processo para a preparação de um sal de cloreto de hidrogênio, sal de cloreto de hidrogênio, sal de cloreto de hidrogênio cristalino, uso de um sal e uso do processo
AU2011254656B2 (en) 2010-05-19 2015-04-16 Sandoz Ag Process for the preparation of chiral hydrazides
MX342850B (es) 2010-05-19 2016-10-14 Sandoz Ag Proceso para la preparacion de triazolonas quirales.
WO2013186320A1 (en) 2012-06-14 2013-12-19 Sandoz Ag Pharmaceutical composition comprising crystalline posaconazole

Also Published As

Publication number Publication date
AU2011254657B2 (en) 2016-02-04
EP2571868B1 (en) 2016-05-04
CA2798007C (en) 2018-10-23
CA2798007A1 (en) 2011-11-24
RU2012154807A (ru) 2014-06-27
CN102892762A (zh) 2013-01-23
US9073904B2 (en) 2015-07-07
EP2571868A1 (en) 2013-03-27
WO2011144656A1 (en) 2011-11-24
BR112012029226A2 (pt) 2015-10-20
AU2011254657A1 (en) 2012-12-20
US20130203994A1 (en) 2013-08-08
JP2013532131A (ja) 2013-08-15
MX2012013332A (es) 2013-02-01
CN102892762B (zh) 2016-04-20
RU2580318C2 (ru) 2016-04-10

Similar Documents

Publication Publication Date Title
MX338514B (es) Preparacion de intermediarios de posaconazol.
PH12015501585A1 (en) Manufacturing process for pyrimidine derivatives
MY193277A (en) Certain amino-pyrimidines, compositions thereof, and methods for their use
MX2010002902A (es) Pirimidinas anti-infecciosas y usos de las mismas.
MY165087A (en) Neprilysin inhibitors
IL223423A (en) History of 6.5 Dihydro-2 h- [1,4] Oxazin-3-Ill-Amine Used as Inhibitors in Scarlet Cell
WO2010111436A3 (en) Antiviral compounds and uses thereof
WO2012136383A3 (en) Preparation of sitagliptin intermediates
IN2014CN04449A (es)
MY160392A (en) Triptolide prodrugs
PH12014502492A1 (en) Pyrazole compounds as sglt1 inhibitors
IN2014DN01629A (es)
IN2014MN01671A (es)
WO2012140490A3 (en) Processes for preparing pitavastatin calcium
MY164880A (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
WO2012063115A3 (en) Process for the preparation of rosuvastatin calcium via novel amine intermediate
IN2012DN02000A (es)
MX2013009388A (es) Nuevos compuestos de azaespirodecanona como inhibidores de lipasa sensible a hormonas (hsl).
EP2575465A4 (en) Raltegravir SALTS
MX2013002656A (es) Nuevo proceso.
MX2013013021A (es) Nuevos compuestos de hexahidropirroloimidazolona.
WO2011157670A3 (en) Process for the preparation of benzamide derivatives
WO2012008763A3 (en) Composition for preventing hair loss and stimulating hair growth
CL2009000346A1 (es) Compuestos derivados de pirimidilmetilsulfonamida; procedimiento para preparar dichos compuestos; compuesto intermediario de formula ixa; composicion agroquimica; metodo para combatir hongos daninos fitopatogenos, y uso de dichos compuestos.
WO2011014613A3 (en) Preparation of fipamezole

Legal Events

Date Code Title Description
FG Grant or registration